Searched for
LUPIN FACILITY
Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...04 May, 2026, 06.00 AM IST- Stocks in news: HDFC Bank, ICICI Bank, RIL, Trent, Jio FinancialIndian markets are set for a dynamic start today. Investors will closely watch the Q4 results from banking giants HDFC Bank and ICICI Bank....20 Apr, 2026, 06.21 AM IST
- Lupin to set up new facility in US with an investment of USD 250 mnDrug firm Lupin will establish a new manufacturing plant in Coral Springs, Florida. The investment totals USD 250 million over five years. ...08 Oct, 2025, 07.26 PM IST
- Lupin gets EIR for Pithampur Unit-2, paves way for resolving warning letterThe EIR represents the closure of the inspection, and also paves the way for possible lifting of warning letters on the facility imposed by...11 Jul, 2023, 08.18 PM IST
- Lupin gets warning letter from USFDA for Somerset facilityThe United States Food and Drug Administration (USFDA) had inspected the company's Somerset, New Jersey, facility from September 10, 2020, ...13 Jun, 2021, 04.40 PM IST
- Irish drug regulator clears Lupin Pune unit after virtual inspectionLupin’s Pune facility is known for its R&D and manufacturing work related to biosimilars.10 May, 2021, 12.14 PM IST
- Lupin gets 2 observations from USFDA for Nagpur facility"The inspection closed with two 483 observations," Lupin said.11 Jan, 2020, 03.41 PM IST
- Lupin gets EIR from USFDA for Nagpur facilityUSFDA conducted the inspection between August 5-8, 2019, Lupin said in a filing to the BSE.18 Oct, 2019, 04.01 PM IST
- Lupin gets 3 observations from USFDA for its Tarapur facilityThe inspection of Tarapur facility was carried out by the United States Food and Drug administration (USFDA) between September 16-20, 2019.23 Sep, 2019, 12.46 PM IST
- Sell Lupin, target Rs 800: Elara CapitalSell Lupin at a price target of Rs 800.25 Apr, 2019, 05.25 PM IST
- Lupin Pharma gets Good Manufacturing Certificate for its biologic plantBiosimilar Etanercept is used to fight a range of severe auto-immune disorders.27 Mar, 2019, 06.42 PM IST
- Lupin gets EIR from USFDA for Pithampur facility unitLupin's Pithampur facility manufactures dermatological products, dry product inhalers, and metered dose inhalers.10 Dec, 2018, 03.51 PM IST
- USFDA makes 22 observations post inspection of Lupin's Mandideep facilitiesLupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalospori...05 Dec, 2018, 02.00 PM IST
- Lupin gets EIR from USFDA for Nagpur facilityCommenting on the development, Lupin MD Nilesh Gupta said, "The successful completion of the Nagpur facility inspection is a positive devel...24 Aug, 2018, 11.30 PM IST
- Lupin gets EDQM nod for its Mandideep facilityThe inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with facility inspection for...30 Jul, 2018, 02.30 PM IST
- USFDA completes inspection of Lupin's Nagpur plantNo observations were made following the inspection of the facility that manufactures oral solid products in the coastal state of Maharashtr...14 May, 2018, 11.57 AM IST
- Lupin pharma gets USFDA nod to market ophthalmic solutionThe company said it has received the final approval for its product, a generic version of Allergan Inc's Lumigan Ophthalmic Solution, from ...23 Feb, 2015, 03.52 PM IST
Load More
